Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma

European Journal of Surgical Oncology

Volumn 37, Issue 8, 2011, Pages 681-687

  De Vries, M ^a   Speijers, M J ^a   Bastiaannet, E ^a   Plukker, J Th M ^a   Brouwers, A H ^a   Van Ginkel, R J ^a   Suurmeijer, A J H ^a   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Follow up; Melanoma; Sentinel lymph node; Ulceration

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; BRESLOW THICKNESS; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMPLETION LYMPH NODE DISSECTION; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MELANOMA; METASTASIS; MORBIDITY; MORTALITY; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIMARY CUTANEOUS MELANOMA; PRIMARY CUTENEOUS MELANOMA ULCERATION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL INFECTION; SURVIVAL; THICKNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SKIN ULCER; SURVIVAL ANALYSIS; TUMOR BURDEN; YOUNG ADULT;

EID: 79960200147     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.05.003     Document Type: Article

References (25)

1. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
2. D.L. Morton, J.F. Thompson, A.J. Cochran, and R. Elashoff Sentinel node biopsy and immediate lymphadenectomy for occult metastases versus nodal observation and delayed lymphadenectomy for nodal recurrence: fourth interim analysis of MSLT-1 Ann Surg Oncol 17 Suppl. 1 2010 S22 S23
3. M.H. Doting, H.J. Hoekstra, and J.T. Plukker Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma Eur J Surg Oncol 28 2002 673 678
4. National Cancer Institute. MSLT-II protocol. Available at: http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00297895. [Accessed March 2011].
5. M.P. Mays, R.C. Martin, and A. Burton Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer 116 2010 1535 1544
6. P. Rutkowski, Z.I. Nowecki, and M. Zdzienicki Cutaneous melanoma with nodal metastases in elderly people Int J Dermatol 49 2010 907 913
7. K.M. McMasters, R.D. Noyes, and D.S. Reintgen Lessons learned from the sunbelt melanoma trial J Surg Oncol 86 2004 212 223 (Pubitemid 38880288)
8. D.L. Morton, A.J. Cochran, and J.F. Thompson Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial Ann Surg 242 2005 302 311
9. A.C. van Akkooi, J.H. de Wilt, and C. Verhoef High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma Eur J Cancer 42 2006 372 380 (Pubitemid 43132893)
10. E.H. Doting, M. de Vries, and J.T. Plukker Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol 93 2006 564 570 (Pubitemid 43806992)
11. O.E. Nieweg False-negative sentinel node biopsy Ann Surg Oncol 16 2009 2089 2091
12. C.R. Scoggins, R.C. Martin, and M.I. Ross Factors associated with false-negative sentinel lymph node biopsy in melanoma patients Ann Surg Oncol 17 2010 709 717
13. W.C. Conway, M.B. Faries, and M.B. Nicholl Age-related lymphatic dysfunction in melanoma patients Ann Surg Oncol 16 2009 1548 1552
14. S. Mocellin, J.F. Thompson, and S. Pasquali Sentinel node status prediction by four statistical models: results from a large bi-institutional series (n = 1132) Ann Surg 250 2009 964 969
15. R. Essner, M.H. Chung, and R. Bleicher Prognostic implications of thick (>or = 4 mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy Ann Surg Oncol 9 2002 754 761
16. C. Gajdos, K.A. Griffith, and S.L. Wong Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 115 2009 5752 5760
17. C.R. Scoggins, A.L. Bowen, and R.C. Martin Prognostic information from sentinel lymph node biopsy in patients with thick melanoma Arch Surg 145 2010 622 627
18. A.P. van der Ploeg, A.C. van Akkooi, and P.I. Schmitz EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam criteria Eur J Cancer 46 2010 2414 2421
19. W.R. Wrightson, S.L. Wong, and M.J. Edwards Complications associated with sentinel lymph node biopsy for melanoma Ann Surg Oncol 10 2003 676 680 (Pubitemid 40486900)
20. A.S. Hunting, A. Nopp, and S.G. Johansson Anaphylaxis to patent blue V. I. Clinical aspects Allergy 65 2010 117 123
21. M. de Vries, W.G. Vonkeman, R.J. van Ginkel, and H.J. Hoekstra Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma Eur J Surg Oncol 31 2005 778 783 (Pubitemid 41194657)
22. M. de Vries, W.G. Vonkeman, R.J. van Ginkel, and H.J. Hoekstra Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma Eur J Surg Oncol 32 2006 785 789 (Pubitemid 44276020)
23. M.B. Faries, J.F. Thompson, and A. Cochran The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the multicenter selective lymphadenectomy trial (I) Ann Surg Oncol 17 2010 3324 3329
24. M. de Vries, H.J. Hoekstra, and J.E. Hoekstra-Weebers Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma Ann Surg Oncol 16 2009 2840 2847
25. European Organisation for Research and Treatment of Cancer. MiniTub protocol. Available at: http://www.melanomagroup.eu/content/view/101/117/. [Accessed March 2011].